Skip to main content
. 2017 Mar 30;8(21):34787–34795. doi: 10.18632/oncotarget.16720

Figure 1. Assessment of cut-off value for βLRI, LLRI, NLR, dNLR, M/GLR and PLR in ENKTL patients prior to treatment.

Figure 1

Receiver operating characteristic (ROC) analysis was performed to evaluate the prognostic value of pretreatment βLRI, LLRI, NLR, dNLR, M/GLR and PLR. The area under the ROC curve value was 0.558, 0.559, 0.562, 0.567, 0.563 and 0.512, respectively.